Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01395316
Brief Title: Alemtuzumab on Surrogate Markers of Disease Activity and Repair Using Advanced MRI Measures in Subjects With Relapsing Remitting Multiple Sclerosis

First Submitted : July 13, 2011
First Submitted that Met QC Criteria : July 14, 2011
First Posted : July 15, 2011 (Estimate)

Results First Submitted : November 13, 2018
Results First Submitted that Met QC Criteria : November 13, 2018
Results First Posted : December 7, 2018

Last Update Submitted that Met QC Criteria : November 13, 2018
Last Update Posted : December 7, 2018